glp-1 drugs approved for weight loss GLP1 Drug Use Has Soared Costing Billions What to Make of the
Description
The promising obesity outcomes enabled by drugs such as Wegovy have prompted other drug manufacturers to pursue their own development efforts to help claim their share of this unprecedented market opportunity

J Clin Invest 129, 37863791 (2019)

DOI: 10.2337/db10-0474 Shaefer CF Jr et al (2015): User's guide to mechanism of action and clinical use of GLP-1 receptor agonists

Brereton, M

GlucagonLike Peptide1 Targets in the Human Nodose Ganglion. Journal of Comparative Neurology , vol
